Irish Life Investment Managers’s West Pharmaceutical WST Stock Holding History

Irish Life Investment Managers’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$104K	Buy	+2,974	New	+$97.9K	﹤0.01%	917

Other funds holding WST

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Irish Life Investment Managers's WST Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in West Pharmaceutical (WST) in Q2 2013: 2,974 shares worth $104K. The stake represents ﹤0.01% of the portfolio and ranks #917 among its holdings.

197 funds tracked by Wall St. Rank hold WST as of Q2 2013.

Irish Life Investment Managers held 2,974 shares of West Pharmaceutical worth $104K as of Q2 2013.
West Pharmaceutical was a new Irish Life Investment Managers position in Q2 2013.
West Pharmaceutical made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #917 holding.
197 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.